可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Giannessi D,Maltinti M,Del Ry S.Adiponectin circulating levels:A new emergingbiomarker of cardiovascular risk[J].Pharmacol Res,2007,56(6):459-467.
[2]中华医学会心血管病分会,中华心血管病杂志编委会,中国心肌病诊断与治疗建议工作组.心肌病诊断与治疗建议[J].中华心血管病杂志,2007,35(1):3-16.
[3]Francone M.Role of cardiac magnetic resonance in the evaluation of dilated cardiomyopathy: diagnostic contribution and prognostic significance[J].Radiology,2014,2014:365404.
[4]Feldman AM,Begay RL,Knezevic T,et al.Decreased levels of BAG3 in a family with a rare variant and in idiopathic dilated cardiomyopathy[J].J Cell Physiol,2014,229(11):1697-1702.
[5]Kawai C,Matsumori A.Dilated cardiomyopathy update:infectious-immune theory revisited[J].Heart Fail Rev,2013,18(6):703-714.
[6]Sandi RM,Pol KG,Basavaraj P,et al.Association of Serum Cholesterol,Triglyceride,High and Low Density Lipoprotein(HDL and LDL)Levels in Chronic Periodontitis Subjects with Risk for Cardiovascular Disease (CVD):A Cross Sectional Study[J].J Clin Diagn Res,2014,8(1):214-216.
[7]Rothnie A,Theron D,Soceneantu L,et al.The importance of cholesterol in maintenance of P-glycoprotein activity and its membrane perturbing influence[J].Eur Biophys J,2001,30(6):430-442.
[8]张广伟.细胞膜胆固醇通过PKC通路调节心肌Connexin43的表达和分布[D].福建:厦门大学,2014.
[9]Granér M,Pentik?inen MO,Nyman K,et al.Cardiac steatosis in patients with dilated cardiomyopathy[J].Heart,2014,100(14):1107-1112.
[10]Giannessi D,Caselli C,Del Ry S,et al.Adiponectin is associated with abnormal lipid profile and coronary microvascular dysfunction in patients with dilated cardiomyopathy without overt heart failure[J].Metabolism,2011,60(2):227-233.
[11]郭勇娟.扩张型心肌病患者血脂与血尿酸、高敏C-反应蛋白水平及心功能关系[D].浙江:浙江大学,2007.
[12]Christ M,Klima T,Grimm W,et al.Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy[J].Eur Heart J,2006,27(6):691-699.
[13]李鹏飞,杨 波,王 鑫,等.扩张型心肌病患者血清PAB、HDL-C、hs-CRP水平及意义[J].疑难病杂志,2011,10(1):2-4.